MedPath

The effectiveness of Ibuprofen and Lorazepam combination therapy in treating the symptoms of acute migraine

Phase 4
Completed
Conditions
Ethics Committee Branch of Tonekabon Islamic Azad University has approved the study design. Participation in the study is voluntary. Each of the study participants were able to recognize and feel them
Migraine&#44
Acute&#44
Treatment&#44
Ibuprofen&#44
Lorazepam
Registration Number
TCTR20160927003
Lead Sponsor
Azad Islamic University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
90
Inclusion Criteria

patients with an average of two to six attacks per month and an initial diagnosis of migraine based on the International Headache Society (HIS) criteria were selected through convenience sampling

Exclusion Criteria

patients that was diagnosed of migraine absolutely

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Migraine at 3 months after end of the intervention The International Headache Society’s Scale, Migraine at 3 months after end of the intervention The International Headache Society’s Scale
Secondary Outcome Measures
NameTimeMethod
nausea and vomiting at 3 months after end of the intervention Patient reported outcome using a questionnaire interview
© Copyright 2025. All Rights Reserved by MedPath